Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Role of IL-2 secreted by PADRE-specific CD4+ T cells in enhancing E7-specific CD8+ T-cell immune responses

A Corrigendum to this article was published on 15 April 2008

Abstract

CD4+ T helper cells are known to play an integral role in the generation of CD8+ T-cell immune responses. We have previously shown that co-administration of DNA vaccines containing E6 or E7 protein of human papillomavirus 16 (HPV-16) combined with DNA encoding invariant (Ii) chain in which class II-associated Ii peptide (CLIP) region is replaced with the CD4+ T helper epitope, PADRE (Pan-DR-epitope) (Ii-PADRE DNA) enhanced HPV antigen-specific CD8+ T-cell immune responses in vaccinated mice. In the current study, we investigated the enhancement of HPV E7-specific CD8+ T-cell immune responses by PADRE-specific CD4+ T cells. We showed that intradermal administration of Ii-PADRE DNA at the same location as E7-expressing DNA is necessary to generate strong E7-specific CD8+ T-cell immune responses. We also showed that PADRE-specific CD4+ T cells generated by Ii-PADRE DNA vaccination expressed Th1 cytokine profile. Furthermore, our in vitro study demonstrated that PADRE-specific CD4+ T cells stimulated with PADRE-loaded dendritic cells secrete IL-2 that leads to the proliferation of E7-specific CD8+ T cells. Thus, our data suggest that activated PADRE-specific CD4+ T helper cells may be required at the vicinity of E7-specific CD8+ T cells where they secrete IL-2, which enhances the E7-specific CD8+ T-cell immune responses generated by DNA vaccination.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA . DNA vaccines. Annu Rev Immunol 1997; 15: 617–648.

    Article  CAS  PubMed  Google Scholar 

  2. Gurunathan S, Klinman DM, Seder RA . DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 2000; 18: 927–974.

    Article  CAS  PubMed  Google Scholar 

  3. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo Jr LD . DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996; 2: 1122–1128.

    Article  CAS  PubMed  Google Scholar 

  4. Porgador A, Irvine KR, Iwasaki A, Barber BH, Restifo NP, Germain RN . Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J Exp Med 1998; 188: 1075–1082.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hung CF, Wu TC . Improving DNA vaccine potency via modification of professional antigen presenting cells. Curr Opin Mol Ther 2003; 5: 20–24.

    CAS  PubMed  Google Scholar 

  6. Tsen SW, Paik AH, Hung CF, Wu TC . Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells. Expert Rev Vaccines 2007; 6: 227–239.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Castellino F, Germain RN . Cooperation between CD4+ and CD8+ T cells: when, where, and how. Annu Rev Immunol 2006; 24: 519–540.

    Article  CAS  PubMed  Google Scholar 

  8. Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H . The central role of CD4(+) T cells in the antitumor immune response. J Exp Med 1998; 188: 2357–2368.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Marzo AL, Kinnear BF, Lake RA, Frelinger JJ, Collins EJ, Robinson BW et al. Tumor-specific CD4+ T cells have a major ‘post-licensing’ role in CTL mediated anti-tumor immunity. J Immunol 2000; 165: 6047–6055.

    Article  CAS  PubMed  Google Scholar 

  10. Hung CF, Tsai YC, He L, Wu TC . DNA vaccines encoding Ii-PADRE generates potent PADRE-specific CD4(+) T-cell immune responses and enhances vaccine potency. Mol Ther 2007; 15: 1211–1219.

    Article  CAS  PubMed  Google Scholar 

  11. Lin KY, Lu D, Hung CF, Peng S, Huang L, Jie C et al. Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion. Cancer Res 2007; 67: 1832–1841.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Mitchison NA, O'Malley C . Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response. Eur J Immunol 1987; 17: 1579–1583.

    Article  CAS  PubMed  Google Scholar 

  13. Bennett SR, Carbone FR, Karamalis F, Miller JF, Heath WR . Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med 1997; 186: 65–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Bousso P, Robey E . Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes. Nat Immunol 2003; 4: 579–585.

    Article  CAS  PubMed  Google Scholar 

  15. Bevan MJ . Helping the CD8(+) T-cell response. Nat Rev Immunol 2004; 4: 595–602.

    Article  CAS  PubMed  Google Scholar 

  16. Xiang J, Huang H, Liu Y . A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells. J Immunol 2005; 174: 7497–7505.

    Article  CAS  PubMed  Google Scholar 

  17. Keene JA, Forman J . Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med 1982; 155: 768–782.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Cassell D, Forman J . Linked recognition of helper and cytotoxic antigenic determinants for the generation of cytotoxic T lymphocytes. Ann NY Acad Sci 1988; 532: 51–60.

    Article  CAS  PubMed  Google Scholar 

  19. Alexander J, Sidney J, Southwood S, Ruppert J, Oseroff C, Maewal A et al. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1994; 1: 751–761.

    Article  CAS  PubMed  Google Scholar 

  20. Lin K-Y, Guarnieri FG, Staveley-O'Carroll KF, Levitsky HI, August T, Pardoll DM et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 1996; 56: 21–26.

    CAS  PubMed  Google Scholar 

  21. Shen Z, Reznikoff G, Dranoff G, Rock KL . Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997; 158: 2723–2730.

    CAS  PubMed  Google Scholar 

  22. Ji H, Wang T-L, Chen C-H, Hung C-F, Pai S, Lin K-Y et al. Targeting HPV-16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine HPV-16 E7-expressing tumors. Hum Gene Ther 1999; 10: 2727–2740.

    Article  CAS  PubMed  Google Scholar 

  23. Hung CF, Tsai YC, He L, Coukos G, Fodor I, Qin L et al. Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice. Gene Ther 2007; 14: 20–29.

    Article  CAS  PubMed  Google Scholar 

  24. Cheng WF, Hung CF, Chai CY, Hsu KF, He L, Ling M et al. Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest 2001; 108: 669–678.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Chen CH, Wang TL, Hung CF, Yang Y, Young RA, Pardoll DM et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res 2000; 60: 1035–1042.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge Dr Richard Roden for helpful discussions and critical review of the manuscript and Ms Talia Hoory for assistance in preparation of the manuscript. This study was supported by the Flight Attendant Medical Research Institute Young Clinical Scientist Award, the National Cancer Institute SPORE in Cervical Cancer P50 CA098252 and the 1 RO1 CA114425-01.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T-C Wu.

Additional information

Supplementary Information accompanies the paper on Gene Therapy website (http://www.nature.com/gt)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, D., Monie, A., He, L. et al. Role of IL-2 secreted by PADRE-specific CD4+ T cells in enhancing E7-specific CD8+ T-cell immune responses. Gene Ther 15, 677–687 (2008). https://doi.org/10.1038/sj.gt.3303102

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3303102

Keywords

This article is cited by

Search

Quick links